Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
New funding for local HIV prevention

Public Health England (PHE) announces an HIV Prevention Innovation Fund for 2016 to 2017 of up to £600,000 for local prevention initiatives.

Published
10 May 2016
From
Public Health England
Is the UK meeting its national guidelines for HIV testing of MSM?

The potential role of frequent HIV testing in curbing the HIV epidemic among the MSM population has long been recognized. The introduction of the strategy of ‘opt-out’ testing in the UK (2007), as in other countries at around the same time, brought a steep rise in testing, followed by stabilization (McDaid & Hart (STIs); Saxton […]

Published
10 May 2016
From
BMJ Group blogs
Gilead's $1000 hepatitis C pill gets patent in India

In what could be a major setback to access to treatment in high-burden countries, the Indian Patent Office on Monday granted a patent to Gilead Pharmasset on Sovaldi (sofosbuvir), its blockbuster drug for hepatitis C, for which the company charges $1,000 per pill in the US.

Published
10 May 2016
From
Times of India
New report shows that urgent action is needed to end the AIDS epidemic by 2030

New report from the United Nations Secretary-General warns that major gains could be lost if action does not accelerate over the next five years and urges countries to react by front-loading investments and increasing action.

Published
09 May 2016
From
UNAIDS
US on course to end its HIV epidemic – eventually

If current trends continue, the US may eventually end its HIV epidemic, a mathematical model recently published in AIDS & Behavior shows. In 2009, the average

Published
09 May 2016
By
Gus Cairns
Sky-high price of hepatitis C drug produces profits for lawmakers

While patients in Massachusetts await affordable doses of the blockbuster hepatitis C drug Sovaldi, Rep. Joseph Kennedy III has financially benefited from the success of the drug’s manufacturer, Gilead Sciences, according to public financial disclosures and campaign finance records.

Published
05 May 2016
From
Center for Responsive Politics
PrEP in the Wild — A whirlwind tour of the who, what, where and how of PrEP use and provision outside of approval

In this webinar, presenters spoke about PrEP’s use and provision in countries that haven’t yet approved it or who are in the early days post approval. Among others, these presenters from Thailand, South Africa, England, Peru, Mexico and the United States took on the following questions and more:

Published
05 May 2016
From
AVAC
Second update to the BHIVA-BASHH Position Statement on PrEP in the UK

This second update follows the recent NHS England decision on the commissioning and provision of pre-exposure prophylaxis (PrEP) for HIV prevention in which they declined to recommend a full roll-out of PrEP but offered £2 million for a small pilot implementation project.

Published
04 May 2016
From
BHIVA / BASHH
It’s Tough to Stop Sex, Study of U.S. AIDS Effort Shows

Researchers have found no benefits from a decade-long attempt to curb the spread of HIV in Africa by promoting abstinence and monogamy. The U.S. has spent more than $1.4 billion since 2004 telling young people in Africa to abstain from sex before marriage and then commit to a single partner. That funding didn’t influence the number of sex partners people had, the age at which they started having sex, or teen pregnancy rates, according to a study published on Monday. See http://www.aidsmap.com/page/2949285/ for more on this issue.

Published
04 May 2016
From
Bloomberg
The Drugs Consensus Is Not Pretty - It's Been Ripped Apart at the Seams

The UNGASS was certainly not a success for the defenders of the status quo. The consensus on punitive prohibition has been well and truly ripped apart at the seams. This UNGASS demonstrates the impact civil society pressure can achieve. The drug policy reform movement will continue to grow into a formidable global social movement towards 2019. The collective demand for change will grow ever louder leading to sustainable and seismic break-throughs at national, regional and ultimately UN levels.

Published
04 May 2016
From
International Drug Policy Consortium

Filter by country